deficiencies found as part of evaluation? B6 Does the firm communicate to person who take care of in-house training to include the deficiencies area in the next training course cycle? B7 Whether the policies

the quality risks in Acceptance and Continuance of Client Relationships and Specific Engagement element that the firm considers as high risk? Please describe the relevant responses to these risks. A.1

already has a share of intermittent renewables deployment of at least 20% or has credible evidence of programmes in place that increase the share of intermittent renewables to this level within the next 10

element that the firm considers as high risk? Please describe the relevant responses to these risks. A.1 Information System: Firm's Reference /Guidance Notes Description 1 How does the firm determine what

(มหาชน) AQUA 3 Warrants บริษัท บี จิสติกส์ จำกัด (มหาชน) ใบสำคัญแสดงสิทธิที่จะซื้อหุ้นสามัญของบริษัท บี จิสติกส์ จำกัด (มหาชน) B-W7 3 บริษัท บิ๊ก คาเมร่า คอร์ปอเรชั่น จำกัด (มหาชน) BIG 3 บริษัท บรุ๊คเคอร์

5.48589 BEAUTY 139,877,292 4.67162 BEC 226,587,333 11.32937 BEM 585,130,730 3.82814 BEYOND 63,127,921 21.85351 BGC 8,730,019 1.25712 BGRIM 13,646,639 0.52348 BGT 1,294,198 0.35602 BH 3,555,096 0.44725 BIG

BEM 671,884,606 4.39571 BEYOND 62,974,021 21.80023 BGC 8,490,521 1.22264 BGRIM 11,316,305 0.43409 BGT 382,109 0.10511 BH 3,274,822 0.41199 BIG 127,485,258 3.61263 BIOTEC 272,019,614 8.90918 BIS

4.20047 BEC 179,315,575 8.96578 BEM 687,110,673 4.49533 BEYOND 62,771,021 21.64006 BGC 8,331,719 1.19977 BGRIM 8,061,873 0.30925 BGT 382,108 0.10511 BH 3,261,618 0.41033 BIG 127,500,770 3.61307 BIOTEC

68,717,078 2.29501 BEC 139,084,189 6.95421 BEM 326,628,406 2.13692 BEYOND 60,797,421 20.95967 BGC 7,989,421 1.15048 BGRIM 6,502,703 0.24944 BGT 382,108 0.10511 BH 3,224,906 0.40571 BIG 100,918,379 2.85979

BH 3,604,816 0.45350 BIG 128,649,109 3.64561 BIOTEC 269,103,618 8.81367 BIOTEC-W2 33,300 0.00328 BIS 17,731,310 5.64691 BIZ 2,117,095 0.35242 BJC 6,142,684 0.15327 BJCHI 27,813,560 1.73868 BKD